Cognitive function and retinal and ischemic brain changes: The Women's health initiative

Neurology

Volumn 78, Issue 13, 2012, Pages 942-949

  Haan, M ^a   Espeland, M A ^f   Klein, B E ^g   Casanova, R ^c   Gaussoin, S A ^c   Jackson, R D ^e   Millen, A E ^c   Resnick, S M ^h   Rossouw, J E ⁱ   Shumaker, S A ^d   Wallace, R ^j   Yaffe, K ^b,c  

^a Departments of Epidemiology and Biostatistics   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Wake Forest Baptist Health   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

^h NATIONAL INSTITUTE ON AGING   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j UNIVERSITY OF IOWA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; FRONTAL LOBE; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PARIETAL LOBE; PRIORITY JOURNAL; RETINOPATHY; RISK ASSESSMENT; RISK FACTOR; TEMPORAL LOBE; WHITE MATTER LESION; WOMEN'S HEALTH;

EID: 84860833033     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824d9655     Document Type: Article

References (38)

1. Wong TY, Klein R, Amirul Islam FM, et al. Three-year incidence and cumulative prevalence of retinopathy: The Atherosclerosis Risk in Communities study. Am J Ophthalmol 2007;143:970-976. (Pubitemid 46764650)
2. Haan MN. Therapy insight: Type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease. Nat Clin Pract Neurol 2006;2:159-166.
3. van den Berg E, Kessels RP, Kappelle LJ, de Haan EH, Biessels GJ. Type 2 diabetes, cognitive function and dementia: Vascular and metabolic determinants. Drugs Today 2006;42:741-754. (Pubitemid 46079582)
4. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: A 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 2004;164:1327-1333. (Pubitemid 38828884)
5. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004;63:658-663. (Pubitemid 39100821)
6. Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007;64:570-575. (Pubitemid 46588347)
7. Reitz C, Tang MX, Manly J, Mayeux R, Luchsinger JA. Hypertension and the risk of mild cognitive impairment. Arch Neurol 2007;64:1734-1740. (Pubitemid 350254935)
8. Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74. (Pubitemid 34705520)
9. Wong TY, Mosley TH Jr, Klein R, et al. Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 2003;61:806-811. (Pubitemid 37174477)
10. Haan MN, Klein R, Klein BE, et al. Hormone therapy and age-related macular degeneration: The Women's Health Initiative Sight Exam Study. Arch Ophthalmol 2006;124: 988-992. (Pubitemid 44036321)
11. Jaramillo SA, Felton D, Andrews L, et al. Enrollment in a brain magnetic resonance study: Results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol 2007;14:603-612. (Pubitemid 46551760)
12. Coker LH, Espeland MA, Rapp SR, et al. Postmenopausal hormone therapy and cognitive outcomes: The Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol 2010;118:304-310.
13. Resnick SM, Espeland MA, Jaramillo SA, et al. Postmenopausal hormone therapy and regional brain volumes: The WHIMS-MRI Study. Neurology 2009;72:135-142.
14. Klein R, Deng Y, Klein BE, et al. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol 2007;143:473-483.
15. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998;19:604-621. (Pubitemid 29057725)
16. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333. (Pubitemid 34761611)
17. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA. The Women's Health Initiative Study of Cognitive Aging (WHISCA): A randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004;1:440-450.
18. Anderson G, Cummings S, Freedman LS, et al. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials 1998;19:61-109. (Pubitemid 28085557)
19. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987;48:314-318. (Pubitemid 17138128)
20. Littell RC, Henry PR, Ammerman CB. Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 1998;76:1216-1231. (Pubitemid 128437870)
21. Sonnen JA, Larson EB, Crane PK, et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 2007;62:406-413. (Pubitemid 350105954)
22. White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002;977: 9-23. (Pubitemid 35418132)
23. Cheung N, Mosley T, Islam A, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: A prospective study. Brain 2010;133:1987-1993.
24. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL. Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 2002;59:1536-1540. (Pubitemid 35387058)
25. Longstreth W Jr, Larsen EK, Klein R, et al. Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: The Cardiovascular Health Study. Am J Epidemiol 2007;165:78-84. (Pubitemid 46026212)
26. Cooper LS, Wong TY, Klein R, et al. Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: The Atherosclerosis Risk in Communities Study. Stroke 2006;37:82-86. (Pubitemid 43732052)
27. Qiu C, Cotch MF, Sigurdsson S, et al. Retinal and cerebral microvascular signs and diabetes: The age, gene/environment susceptibility-Reykjavik study. Diabetes 2008;57: 1645-1650.
28. Lesage SR, Mosley TH, Wong TY, et al. Retinal microvascular abnormalities and cognitive decline: The ARIC 14-year follow-up study. Neurology 2009;73:862-868.
29. Ding J, Strachan MW, Reynolds RM, et al. Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Diabetes 2010;59:2883-2889.
30. Kawasaki R, Cheung N, Mosley T, et al. Retinal microvascular signs and 10-year risk of cerebral atrophy: The Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010;41:1826 -1828.
31. Wessels AM, Simsek S, Remijnse PL, et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474-2480. (Pubitemid 44359110)
32. Lindley RI, Wang JJ, Wong MC, et al. Retinal microvasculature in acute lacunar stroke: A cross-sectional study. Lancet Neurol 2009;8:628-634.
33. Liu Y, Wu Y, Xie S, Luan XH, Yuan Y. Retinal arterial abnormalities correlate with brain white matter lesions in cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy. Clin Experiment Ophthalmol 2008;36:532-536.
34. Tooze JA, Gaussoin SA, Resnick SM, et al. A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: The Women's Health Initiative Magnetic Resonance Imaging study. Neuroepidemiology 2010;34:55-62.
35. McNaull BB, Todd S, McGuinness B, Passmore AP. Inflammation and anti-inflammatory strategies for Alzheimer's disease: A mini-review. Gerontology 2010;56:3-14.
36. Gouw AA, Seewann A, van der Flier WM, et al. Heterogeneity of small vessel disease: A systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011;82:126-135.
37. Messier C, Teutenberg K. The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer's disease. Neural Plast 2005;12: 311-328. (Pubitemid 43072007)
38. Margolis KL, Lihong Q, Brzyski R, et al. Validity of diabetes self-reports in the Women's Health Initiative: Comparison with medication inventories and fasting glucose measurements. Clin Trials 2008;5:240-247.